| ORIGINAL ARTICLE |
|
| Year : 2001 | Volume
: 17
| Issue : 2 | Page : 124-126 |
|
|
B. C. G. plus recombinant interferon α2b in superficial bladder cancer
Gyan Prakash Singh, Usha Singh, US Diwedi, PB Singh
Departments of Urology and Immunology, Institute of Medical Sciences, B.H. U., Varanasi, India
Correspondence Address:
P B Singh
Dept. of Urology, Institute of Medical Sciences, B.H.U., Varanasi - 221 005
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
We have studied the efficacy of adjuvant therapy in the form of low dose B.C.G. and interferon alpha 2b. In the present study 7patients with superficial bladder carcinoma (6 recurrent and I primary) have been treated by TURBT and intravesical instillation of B. C. G. 80 mg plus interferon alpha 2b 10 million units weekly for 8 weeks. All patients accepted the therapy without significant morbidity and complication. Follow-up,period ranges between 11-16 months and none of the patients have developed recurrence till date.
Interferon alpha 2b along with B.C.G. is a good alternative agent, for prophylaxis in case of high grade and recurrent bladder tumour |
|
|
|
| [FULL TEXT] [PDF Not available]* |
|
 |
|
